![Daniel Zabrowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Daniel Zabrowski
Directeur/Membre du Conseil chez
ACTUATE THERAPEUTICS, INC.
Fortune : 154 223 $ au 31/05/2026
Profil
Daniel Zabrowski is the founder of M2SC Consulting LLC.
Current positions include Executive Chairman at Nimble Therapeutics, Inc. since 2019, Director at Omniome LLC, Independent Director at Endogena Therapeutics, Inc. since 2018, Director at Apexigen America, Inc. since 2014, Independent Director at Coagulo Medical Technologies, Inc., Independent Director at Actuate Therapeutics, Inc. since 2021, Director at AccuraGen, Inc. since 2013, Director at Ariagen, Inc. since 2018, and Venture Partner at Decheng Capital LLC since 2016.
Former roles include Director at Chugai Pharmaceutical Co., Ltd., Associate Director at Fujisawa Healthcare, Inc. in 1993, Executive Director-Drug Regulatory Affairs at Syntex (USA), Inc. in 1995, Director at Exosome Diagnostics, Inc., Independent Director at BeyondSpring, Inc. from 2020 to 2022, Director at Encodia, Inc., Independent Director at Apexigen, Inc. from 2016 to 2023, Head-Roche Sequencing Solutions at Roche Holding AG from 2013 to 2016, President-Roche Sequencing Unit at Ventana Medical Systems, Inc., Manager-Regulatory Affairs at G.D.
Searle LLC, Global Head-Drug Regulatory Affairs at Roche Pharma (Schweiz) AG from 1994 to 2016, and President at Roche Sequencing Solutions, Inc. Education includes a doctorate from Indiana University conferred in 1987 and undergraduate studies at St. Louis University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/05/2026 | 76 348 ( 0,32 % ) | 154 223 $ | 31/05/2026 |
Postes actifs de Daniel Zabrowski
| Sociétés | Poste | Début |
|---|---|---|
| ACTUATE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2021 |
Decheng Capital LLC
 Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Private Equity Investor | 01/07/2016 |
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Directeur/Membre du Conseil | 01/09/2014 |
Coagulo Medical Technologies, Inc.
 Coagulo Medical Technologies, Inc. Packaged SoftwareTechnology Services Develops a portable point-of-care diagnostic platform using microfluidic technology and patent-pending coagulation assays | Directeur/Membre du Conseil | - |
Endogena Therapeutics, Inc.
 Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops endogenous regenerative medicines | Directeur/Membre du Conseil | 01/01/2018 |
Ariagen, Inc.
 Ariagen, Inc. BiotechnologyHealth Technology Develops preclinical stage therapeutic drug products | Directeur/Membre du Conseil | 01/01/2018 |
Nimble Therapeutics, Inc.
 Nimble Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oral peptide therapeutics | Président | 01/01/2019 |
AccuraGen, Inc.
 AccuraGen, Inc. BiotechnologyHealth Technology Engages in cancer diagnostic and research | Directeur/Membre du Conseil | 01/01/2013 |
Omniome LLC
 Omniome LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy | Directeur/Membre du Conseil | - |
Anciens postes connus de Daniel Zabrowski
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Daniel Zabrowski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and sells proprietary instruments and reagent systems | Electronic Technology |
Omniome LLC
Omniome LLC Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company which develops proprietary DNA sequencing platform capable of delivering unsurpassed sequencing accuracy | Commercial Services |
Chugai Pharmaceutical Co., Ltd.
 Chugai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries manufactures & sells pharmaceutical products | Health Technology |
Indiana University
 Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fujisawa Healthcare, Inc. | |
Syntex (USA), Inc.
 Syntex (USA), Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Exosome Diagnostics, Inc.
 Exosome Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a biofluid-based diagnostic center | Health Services |
Roche Pharma (Schweiz) AG
 Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
G.D. Searle LLC | |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Decheng Capital LLC
Decheng Capital LLC Investment ManagersFinance Decheng Capital LLC invests in life sciences companies which have strong links to China. It targets companies operating in the fields of Health Technology, Health Services and Technology Service sector. It provides financing for incubation to later stage capital requirements and takes lead or co-lead position. It invests in both public and private companies | Finance |
Actuate Therapeutics, Inc.
 Actuate Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel therapeutics which target cancers and neurodegenerative diseases | Health Technology |
AccuraGen, Inc.
AccuraGen, Inc. BiotechnologyHealth Technology Engages in cancer diagnostic and research | Health Technology |
BeyondSpring, Inc.
 BeyondSpring, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures cancer therapies | Health Technology |
Nimble Therapeutics, Inc.
Nimble Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops oral peptide therapeutics | Health Technology |
Encodia, Inc.
 Encodia, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development in biotechnology | Commercial Services |
Roche Sequencing Solutions, Inc.
 Roche Sequencing Solutions, Inc. Medical/Nursing ServicesHealth Services Provides diagnostics and treatments services | Health Services |
Ariagen, Inc.
Ariagen, Inc. BiotechnologyHealth Technology Develops preclinical stage therapeutic drug products | Health Technology |
Endogena Therapeutics, Inc.
Endogena Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops endogenous regenerative medicines | Health Technology |
Coagulo Medical Technologies, Inc.
Coagulo Medical Technologies, Inc. Packaged SoftwareTechnology Services Develops a portable point-of-care diagnostic platform using microfluidic technology and patent-pending coagulation assays | Technology Services |
M2SC Consulting LLC | |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
